期刊文献+

Magnetic resonance imaging of the cirrhotic liver: An update 被引量:5

Magnetic resonance imaging of the cirrhotic liver: An update
下载PDF
导出
摘要 Noninvasive imaging has become the standard for hepatocellular carcinoma(HCC) diagnosis in cirrhotic livers. In this review paper, we go over the basics of MR imaging in cirrhotic livers and describe the imaging appearance of a spectrum of hepatic nodules marking the progression from regenerative nodules to low- and high-grade dysplastic nodules, and ultimately to HCCs. We detail and illustrate the typical imaging appearancesof different types of HCC including focal, multifocal, massive, diffuse/infiltrative, and intra-hepatic metastases; with emphasis on the diagnostic value of MR in imaging these lesions. We also shed some light on liver imaging reporting and data system, and the role of different magnetic resonance imaging(MRI) contrast agents and future MRI techniques including the use of advanced MR pulse sequences and utilization of hepatocyte-specific MRI contrast agents, and how they might contribute to improving the diagnostic performance of MRI in early stage HCC diagnosis. Noninvasive imaging has become the standard forhepatocellular carcinoma (HCC) diagnosis in cirrhoticlivers. In this review paper, we go over the basics ofMR imaging in cirrhotic livers and describe the imagingappearance of a spectrum of hepatic nodules markingthe progression from regenerative nodules to low- andhigh-grade dysplastic nodules, and ultimately to HCCs.We detail and illustrate the typical imaging appearancesof different types of HCC including focal, multifocal,massive, diffuse/infiltrative, and intra-hepaticmetastases; with emphasis on the diagnostic value ofMR in imaging these lesions. We also shed some lighton liver imaging reporting and data system, and therole of different magnetic resonance imaging (MRI)contrast agents and future MRI techniques includingthe use of advanced MR pulse sequences and utilizationof hepatocyte-specific MRI contrast agents, and howthey might contribute to improving the diagnosticperformance of MRI in early stage HCC diagnosis.
出处 《World Journal of Hepatology》 CAS 2015年第3期468-487,共20页 世界肝病学杂志(英文版)(电子版)
关键词 Magnetic resonance IMAGING Hepatocellularcarcinoma HEPATIC NODULES LIVER IMAGING reportingand data system DYSPLASTIC NODULES Regenerativenodules Magnetic resonance imaging Hepatocellular carcinoma Hepatic nodules Liver imaging reporting and data system Dysplastic nodules Regenerative nodules
  • 相关文献

参考文献97

  • 1Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C,Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0,Cancer Incidence and Mortality Worldwide: IARC CancerBaseNo. 11 [Internet]. Lyon, France: International Agency for Researchon Cancer; 2013. Available from: URL: http://globocan.iarc.fr,accessed on day/month/year.
  • 2Surveillance, Epidemiology, and End Results (SEER) Program.SEERStat database: incidence - SEER 9 Regs research data, Nov2009 Sub (1973-2007). Bethesda, MD: National Cancer Institute,2010.
  • 3El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118-1127 [PMID: 21992124 DOI: 10.1056/NEJMra1001683].
  • 4Bruix J, Llovet JM. Major achievements in hepatocellularcarcinoma. Lancet 2009; 373: 614-616 [PMID: 19231618 DOI:10.1016/S0140-6736(09)60381-0].
  • 5Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM,Lok AS. NAFLD may be a common underlying liver diseasein patients with hepatocellular carcinoma in the United States.Hepatology 2002; 36: 1349-1354 [PMID: 12447858 DOI: 10.1053/jhep.2002.36939].
  • 6Bruix J, Sherman M. Management of hepatocellular carcinoma: anupdate. Hepatology 2011; 53: 1020-1022 [PMID: 21374666 DOI:10.1002/hep.24199].
  • 7Digumarthy SR, Sahani DV, Saini S. MRI in detection ofhepatocellular carcinoma (HCC). Cancer Imaging 2005; 5: 20-24[PMID: 16154814 DOI: 10.1102/1470-7330.2005.0005].
  • 8Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, BusuttilRW, Lu DS. CT and MRI improve detection of hepatocellularcarcinoma, compared with ultrasound alone, in patients withcirrhosis. Clin Gastroenterol Hepatol 2011; 9: 161-167 [PMID:20920597 DOI: 10.1016/j.cgh.2010.09.017].
  • 9Kim KA, Kim MJ, Choi JY, Chung YE. Development ofhepatocellular carcinomas in patients with absence of tumors on aprior ultrasound examination. Eur J Radiol 2012; 81: 1450-1454[PMID: 21514759 DOI: 10.1016/j.ejrad.2011.03.053].
  • 10Arif-Tiwari H, Kalb B, Chundru S, Sharma P, Costello J, GuessnerRW, Martin DR. MRI of hepatocellular carcinoma: an update ofcurrent practices. Diagn Interv Radiol 2014; 20: 209-221 [PMID:24808419 DOI: 10.5152/dir.2014.13370].

同被引文献21

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部